David A. Ahlquist
#160,868
Most Influential Person Now
David A. Ahlquist's AcademicInfluence.com Rankings
David A. Ahlquistphilosophy Degrees
Philosophy
#9273
World Rank
#12807
Historical Rank
Logic
#6257
World Rank
#7758
Historical Rank
Download Badge
Philosophy
Why Is David A. Ahlquist Influential?
(Suggest an Edit or Addition)David A. Ahlquist's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Multitarget stool DNA testing for colorectal-cancer screening. (2014) (1276)
- Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. (2000) (550)
- Increased Risk for Cancer in Patients with the Peutz-Jeghers Syndrome (1998) (437)
- Prospective blinded evaluation of computed tomographic colonography for screen detection of colorectal polyps. (2003) (374)
- Optimization of CT colonography technique: prospective trial in 180 patients. (2000) (357)
- Detection of colorectal polyps with CT colography: initial assessment of sensitivity and specificity. (1997) (328)
- Colorectal cancer screening with CT colonography, colonoscopy, and double-contrast barium enema examination: prospective assessment of patient perceptions and preferences. (2003) (308)
- Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. (1993) (284)
- Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. (2012) (283)
- CT colonography without cathartic preparation: feasibility study. (2001) (271)
- Secreted Frizzled-Related Protein 1 Loss Contributes to Tumor Phenotype of Clear Cell Renal Cell Carcinoma (2007) (270)
- Extracolonic findings at CT colonography: evaluation of prevalence and cost in a screening population. (2003) (260)
- The clinical and endoscopic spectrum of the watermelon stomach. (1992) (250)
- Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. (1998) (232)
- Stool screening for colorectal cancer: molecular approaches. (2005) (230)
- Stool DNA and Occult Blood Testing for Screen Detection of Colorectal Neoplasia (2008) (225)
- Possible role of transforming growth factor alpha in the pathogenesis of Ménétrier's disease: supportive evidence form humans and transgenic mice. (1992) (215)
- Detection of colorectal polyps by computed tomographic colography: feasibility of a novel technique. (1996) (209)
- A prospective, blinded assessment of the impact of preoperative staging on the management of rectal cancer. (2002) (187)
- Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy (2000) (185)
- Fecal blood levels in health and disease. A study using HemoQuant. (1985) (176)
- Gastrointestinal blood loss and anemia in runners. (1984) (165)
- Colorectal Adenomas. (2016) (164)
- Pervasive occult gastrointestinal bleeding in an Alaska native population with prevalent iron deficiency. Role of Helicobacter pylori gastritis. (1997) (159)
- Early Detection of Sporadic Pancreatic Cancer (2015) (158)
- Reducing data size and radiation dose for CT colonography. (1997) (150)
- The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia. (2012) (146)
- Aberrant methylation of secreted frizzled‐related protein genes in esophageal adenocarcinoma and Barrett's esophagus (2005) (146)
- Magnitude of Missed Esophageal Adenocarcinoma After Barrett's Esophagus Diagnosis: A Systematic Review and Meta-analysis. (2016) (138)
- Highly Methylated Genes in Colorectal Neoplasia: Implications for Screening (2007) (137)
- Molecular detection of colorectal neoplasia. (2010) (134)
- Shifts in the Fecal Microbiota Associated with Adenomatous Polyps (2016) (132)
- The "HemoQuant" test: a specific and quantitative determination of heme (hemoglobin) in feces and other materials. (1983) (131)
- Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. (1992) (130)
- Screening for esophageal squamous cell carcinoma: recent advances. (2018) (129)
- Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia. (2013) (127)
- Stool screening for colorectal cancer: evolution from occult blood to molecular markers. (2002) (126)
- Clinically Confirmed Type 2 Diabetes Mellitus and Colorectal Cancer Risk: A Population-Based, Retrospective Cohort Study (2006) (121)
- Stool DNA testing for the detection of pancreatic cancer (2012) (118)
- Patterns of occult bleeding in asymptomatic colorectal cancer (1990) (112)
- Changing trends in the incidence, stage, survival, and screen-detection of colorectal cancer: a population-based study. (2005) (111)
- Clinicopathologic Features and Treatment Outcomes in Cronkhite–Canada Syndrome: Support for Autoimmunity (2012) (106)
- DNA integrity as a potential marker for stool-based detection of colorectal cancer. (2003) (104)
- Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation (2019) (102)
- Duodenal prostaglandin synthesis and acid load in health and in duodenal ulcer disease. (1983) (101)
- High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay. (2009) (101)
- Molecular markers for colorectal cancer screening (2015) (99)
- New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice (2015) (96)
- Acute gastrointestinal bleeding. Experience of a specialized management team. (1992) (95)
- Comparison of the relative sensitivity of CT colonography and double-contrast barium enema for screen detection of colorectal polyps. (2004) (94)
- Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. (2000) (90)
- Contrast-enhanced CT colonography in recurrent colorectal carcinoma: feasibility of simultaneous evaluation for metastatic disease, local recurrence, and metachronous neoplasia in colorectal carcinoma. (2002) (89)
- Care of patients and their families with familial adenomatous polyposis. (2000) (88)
- Morphometric analysis of the "mucocellular layer" overlying colorectal cancer and normal mucosa: relevance to exfoliation and stool screening. (2000) (83)
- HemoQuant, a new quantitative assay for fecal hemoglobin. Comparison with Hemoccult. (1984) (81)
- A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis. (2002) (80)
- Fecal occult blood testing for colorectal cancer. Can we afford to do this? (1997) (80)
- Stool DNA Testing for Screening Detection of Colorectal Neoplasia in Alaska Native People. (2016) (80)
- Prospective study of cutaneous phototoxicity after systemic hematoporphyrin derivative (1988) (79)
- Endoscopic treatment of major bleeding from advanced gastroduodenal malignant lesions. (1994) (79)
- Endoscopic Nd:YAG laser coagulation of bleeding from radiation proctopathy. (1993) (78)
- Mucosal vascular malformations of the gastrointestinal tract: clinical observations and results of endoscopic neodymium: yttrium-aluminum-garnet laser therapy. (1988) (77)
- Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn's colitis (2014) (75)
- Endoscopic laser therapy for watermelon stomach. (1989) (73)
- Nanopore-based assay for detection of methylation in double-stranded DNA fragments. (2015) (73)
- A Sensitive Method to Quantify Human Long DNA in Stool: Relevance to Colorectal Cancer Screening (2006) (68)
- Quantification of methylated markers with a multiplex methylation-specific technology. (2012) (68)
- Detection of Colorectal Serrated Polyps by Stool DNA Testing: Comparison with Fecal Immunochemical Testing for Occult Blood (FIT) (2014) (68)
- Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis (2020) (68)
- Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia (2003) (68)
- Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease (2013) (67)
- Primary sclerosing cholangitis and colorectal carcinoma in patients with chronic ulcerative colitis (1998) (67)
- Endoscopic overestimation of colorectal polyp size. (2016) (67)
- Universal cancer screening: revolutionary, rational, and realizable (2018) (66)
- Frequent Methylation of Eyes Absent 4 Gene in Barrett's Esophagus and Esophageal Adenocarcinoma (2005) (65)
- Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates (2012) (64)
- Laser therapy for severe radiation-induced rectal bleeding. (1986) (62)
- Prostaglandin generation from gastroduodenal mucosa: regional and species differences. (1982) (59)
- Identification and Validation of Colorectal Neoplasia–Specific Methylation Markers for Accurate Classification of Disease (2007) (56)
- A novel method to capture methylated human DNA from stool: implications for colorectal cancer screening. (2007) (52)
- Molecular stool screening for colorectal cancer (2000) (50)
- Computed tomography colonography (virtual colonoscopy): a new method for colorectal screening (1999) (50)
- Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts. (2018) (50)
- Multi-Target Stool DNA Test: A New High Bar for Noninvasive Screening (2015) (49)
- Highly Discriminant Methylated DNA Markers for the Non‐endoscopic Detection of Barrett's Esophagus (2018) (48)
- Aberrant methylation of the eyes absent 4 gene in ulcerative colitis-associated dysplasia. (2006) (46)
- Recent trends in the diagnosis and management of chronic intestinal ischemia (1990) (44)
- A stool collection device: the first step in occult blood testing. (1988) (42)
- Glycerol metabolism in the hibernating black bear (2004) (42)
- Management of gastroduodenopathy associated with use of nonsteroidal anti-inflammatory drugs. (1992) (41)
- Occult blood screening obstacles to effectiveness (1992) (41)
- Association of Peutz‐Jeghers‐like Mucocutaneous Pigmentation with Breast and Gynecologic Carcinomas in Women (2000) (40)
- Next-generation stool DNA testing: expanding the scope. (2009) (39)
- CT colonography: unraveling the twists and turns (2005) (37)
- Accuracy of fecal occult blood screening for colorectal neoplasia: A prospective study using Hemoccult and Hemo‐Quant tests (1993) (36)
- Molecular characterization of colorectal adenomas with and without malignancy reveals distinguishing genome, transcriptome and methylome alterations (2018) (36)
- Colorectal cancer screening: a community case-control study of proctosigmoidoscopy, barium enema radiography, and fecal occult blood test efficacy. (1999) (34)
- Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma (2018) (33)
- Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing. (2019) (32)
- Methylated DNA in Pancreatic Juice Distinguishes Patients With Pancreatic Cancer From Controls. (2020) (32)
- Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening. (2017) (31)
- Fecal marker variability in colorectal cancer: calprotectin versus hemoglobin. (1995) (31)
- Costs associated with Barrett's esophagus screening in the community: an economic analysis of a prospective randomized controlled trial of sedated versus hospital unsedated versus mobile community unsedated endoscopy. (2018) (31)
- Endoscopic laser palliation of malignant dysphagia: a prospective study. (1987) (30)
- Stool DNA Testing for the Detection of Pancreatic Cancer: Identification and Assessment of Methylation Marker Candidates (2011) (29)
- Aggressive polyps in hereditary nonpolyposis colorectal cancer: targets for screening. (1995) (29)
- Intraluminal measurement of enteric mucosal perfusion: relationship to superior mesenteric artery flow during basal and postprandial states in the dog. (1994) (28)
- Systematic review with meta‐analysis: prevalent vs. incident oesophageal adenocarcinoma and high‐grade dysplasia in Barrett's oesophagus (2016) (28)
- Detection of occult upper gastrointestinal tract bleeding: performance differences in fecal occult blood tests. (2002) (28)
- Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma (2019) (26)
- Pseudoinsulinoma syndrome from inadvertent tolazamide ingestion. (1980) (26)
- A Comprehensive Approach to Sequence-oriented IsomiR annotation (CASMIR): demonstration with IsomiR profiling in colorectal neoplasia (2018) (26)
- Analysis of DNA Methylation at Specific Loci in Stool Samples Detects Colorectal Cancer and High‐Grade Dysplasia in Patients With Inflammatory Bowel Disease (2019) (26)
- Computed tomographic colography and virtual colonoscopy. (1997) (25)
- Factors influencing metabolism of arachidonic acid in guinea pig gastric mucosa. (1983) (25)
- Evidence against flat dysplasia as a regional field defect in small bowel adenocarcinoma associated with celiac sprue. (1997) (25)
- Influence of aspirin and ethanol on fecal blood levels as determined by using the HemoQuant assay. (1987) (24)
- DNA Methylation and Mutation of Small Colonic Neoplasms in Ulcerative Colitis and Crohn's Colitis: Implications for Surveillance (2016) (24)
- Molecular detection of pancreatic neoplasia: Current status and future promise. (2015) (23)
- Novel Approach to Fecal Occult Blood Testing by Assay of Erythrocyte-Specific microRNA Markers (2017) (22)
- Fecal hemoglobin excretion in elderly patients with atrial fibrillation: combined aspirin and low-dose warfarin vs conventional warfarin therapy. (1996) (22)
- Long-term Follow-up of Patients Having False-Positive Multitarget Stool DNA Tests after Negative Screening Colonoscopy: The LONG-HAUL Cohort Study (2016) (21)
- Rectal mucosectomy: a definitive approach to extensive hemangiomas of the rectum. (1993) (21)
- Fecal Marker Variability in Colorectal Cancer: Calprotectin versus Hemoglobin (1996) (21)
- Stool-based DNA tests for colorectal cancer: clinical potential and early results. (2002) (20)
- Use of leuco-dyes in the quantitative colorimetric microdetermination of hemoglobin and other heme compounds. (1975) (19)
- Altered DNA mismatch repair expression in synchronous and metachronous colorectal cancers. (2008) (18)
- Improved marker combination for detection of de novo genetic variation and aberrant DNA in colorectal neoplasia. (2006) (18)
- Prospective comparison of contact with noncontact Nd:Yag laser therapy for palliation of esophageal carcinoma. (1989) (18)
- Localization of hematoporphyrin. Derivative to human colorectal cancer (1989) (18)
- Stool Methylated DNA Markers Decrease Following Colorectal Cancer Resection—Implications for Surveillance (2014) (18)
- Accurate Nonendoscopic Detection of Barrett's Esophagus by Methylated DNA Markers: A Multisite Case Control Study (2020) (17)
- A search for germline APC mutations in early onset colorectal cancer or familial colorectal cancer with normal DNA mismatch repair (2001) (17)
- Stool DNA Screening for Colorectal Cancer: Opportunities to Improve Value With Next Generation Tests (2011) (17)
- Methylated Bone Morphogenetic Protein 3 (BMP3) Gene: Evaluation of Tumor Suppressor Function and Biomarker Potential in Biliary Cancer (2013) (17)
- Colorectal Cancer Detection in the Practice Setting: Impact of Fecal Blood Testing (1990) (16)
- Detection of colorectal disease by stool defensin assay: an exploratory study. (2007) (15)
- Screening by CT colonography: too early to pass judgment on a nascent technology. (1999) (15)
- Methylated Eyes Absent 4 (EYA4) Gene Promotor in Non-neoplastic Mucosa of Ulcerative Colitis Patients with Colorectal Cancer: Evidence for a Field Effect (2013) (15)
- Association of primary sclerosing cholangitis and colorectal cancer in patients with ulcerative colitis: is it true and does it matter? (1998) (14)
- Approach to the Patient with Occult Gastrointestinal Bleeding (2009) (14)
- Stool markers for colorectal cancer screening: future considerations. (1996) (14)
- Stool DNA testing for cancer surveillance in inflammatory bowel disease: an early view (2013) (13)
- Stool DNA Analysis is Cost-Effective for Colorectal Cancer Surveillance in Patients With Ulcerative Colitis. (2016) (13)
- T2036 Pan-Detection of Gastrointestinal Neoplasms By Stool DNA Testing: Establishment of Feasibility (2009) (12)
- Aberrantly Methylated Gene Marker Levels in Stool: Effects of Demographic, Exposure, Body Mass, and Other Patient Characteristics (2012) (12)
- Triage by flexible sigmoidoscopy: inevitably "short-sighted". (1998) (12)
- Colorectal cancer detection in the practice setting. Impact of fecal blood testing. (1990) (11)
- Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue (2017) (11)
- Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence (2020) (11)
- Universal detection of aerodigestive cancers by assay of nonapoptotic human DNA in stool (2000) (11)
- Time Lapse to Colorectal Cancer: Telomere Dynamics Define the Malignant Potential of Polyps (2016) (11)
- The mechanisms and prevention of intravascular fluid loss after occlusion of the supraceliac aorta in dogs. (1991) (10)
- Screening for colorectal cancer. (1993) (10)
- Does performance status influence the outcome of Nd:YAG laser therapy of proximal esophageal tumors? (1994) (10)
- Immunodiscrimination of colorectal neoplasia using MUC1 antibodies: discrepant findings in tissue versus stool. (2000) (10)
- Fecal Occult Blood Testing for Iron Deficiency: A Reappraisal (2000) (10)
- Patient perceptions of stool DNA testing for pan-digestive cancer screening: a survey questionnaire. (2014) (10)
- Endoscopic laser coagulation of radiation-induced mucosal vascular lesions in the upper gastrointestinal tract and proximal colon. (1993) (10)
- Laparoscopically assisted panenteroscopy: a feasibility study in pigs. (1995) (9)
- Band ligation-assisted endoscopic resection of a flat rectal adenoma containing infiltrating adenocarcinoma. (1997) (9)
- Second Primary Colorectal Cancer: The Consequence of Management Failure at Several Potential Levels (2002) (9)
- Molecular Detection of Gastrointestinal Neoplasia: Innovations in Early Detection and Screening. (2016) (9)
- Magnetophoretic-based microfluidic device for DNA Concentration (2016) (9)
- Multitarget Stool DNA Screening in Clinical Practice: High Positive Predictive Value for Colorectal Neoplasia Regardless of Exposure to Previous Colonoscopy (2020) (8)
- Multi-target stool DNA test in the surveillance of inflammatory bowel disease: a cross-sectional cohort study (2018) (7)
- Alaska Native Patient and Provider Perspectives on the Multitarget Stool DNA Test Compared With Colonoscopy for Colorectal Cancer Screening (2019) (7)
- Abstract 712: Detection of lung cancer by assay of novel methylated DNA markers in plasma (2017) (7)
- Cost-Effectiveness of Multitarget Stool DNA Testing vs Colonoscopy or Fecal Immunochemical Testing for Colorectal Cancer Screening in Alaska Native People. (2021) (7)
- Morphometric analysis of the “mucocellular layer” overling colorectal cancer and normal mucosa: Relevance to exfoliated stool screening markers (1998) (7)
- Noninvasive Detection of Intraductal Papillary Mucinous Neoplasms (IPMN) and Early Stage Cancer of the Pancreas With Stool DNA Testing (2011) (7)
- T2037 Quantitative Stool DNA Testing for Detection of Both Colorectal Cancer and Advanced Adenoma (2009) (7)
- 109 Discovery of Novel DNA Methylation Markers for the Detection of Colorectal Neoplasia: Selection by Methylome-Wide Analysis (2014) (7)
- Tu1189 An Optimized Multi-Marker Stool Test for Colorectal Cancer Screening: Initial Clinical Appraisal (2012) (7)
- Immunodiscrimination of Colorectal Neoplasia Using MUC1 Antibodies: (2000) (7)
- 743 Noninvasive Detection of Serrated Colorectal Polyps by Stool Assay of Methylated Vimentin and Mutant BRAF Genes (2010) (7)
- T1102 Detection of Colorectal Neoplasia By Stool DNA Testing: High Discrimination with Multi-Marker Quantitation (2008) (7)
- CT colonography of the unprepped colon: An early feasibility study of "virtual preparation" (2000) (6)
- High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9 (2021) (6)
- Detection of Cholangiocarcinoma by Assay of Methylated DNA Markers in Plasma (2017) (6)
- Will molecular genetic markers help predict the clinical behavior of colorectal neoplasia? (1992) (6)
- Measurement of degraded fecal hemoglobin-heme to estimate gastrointestinal site of occult bleeding appraisal of its clinical utility (1988) (6)
- Abstract 4252: Accurate site prediction of gastrointestinal cancer by novel methylated DNA markers: Discovery & validation (2015) (6)
- 298 Discovery, Validation and Feasibility Testing of Highly Discriminant DNA Methylation Markers for Detection of Barrett's Esophagus Using a Capsule Sponge Device (2016) (6)
- Screening in cyberspace: the next generation? (1997) (6)
- 769 Novel Methylated DNA Markers Predict Site of Gastrointestinal Cancer (2013) (5)
- 878 - Accurate Non-Endoscopic Detection of Barrett's Esophagus in a Multicenter Prospective Validation Cohort: The SOS 2 Trial (2018) (5)
- Su1914 Novel Epigenetic Markers for Detection of Esophageal Cancer: Selection by Whole Methylome Sequencing and Tissue Validation (2015) (5)
- Novel methylated DNA markers in plasma detect distant recurrence of colorectal cancer. (2020) (5)
- Fecal Recovery of Ingested Cellular DNA: Implications for Noninvasive Detection of Upper Gastrointestinal Neoplasms (2015) (5)
- Draft Genome Sequences of 24 Microbial Strains Assembled from Direct Sequencing from 4 Stool Samples (2015) (5)
- 113 Non-Invasive Detection of Sessile Serrated Polyps in an Average Risk Colorectal Cancer Screening Population: Comparison of Multi-Target Stool DNA and Fecal Immunochemical Testing (2014) (5)
- Aberrant Gene Methylation in the Neoplastic Progression of Barrett's Esophagus: Identification of Candidate Diagnostic Markers (2011) (4)
- 1044 - Hepatocellular Carcinoma Detection by Plasma Assay of Methylated Dna Markers: Phase II Clinical Validation (2018) (4)
- Defects in prostaglandin synthesis and metabolism in ulcer disease (1986) (4)
- Sa1042 MULTI-TARGET STOOL DNA TESTING ENRICHES DETECTION OF COLORECTAL NEOPLASIA BY COLONOSCOPY BUT YIELD IS INFLUENCED BY BASELINE POLYP DETECTION RATES (2019) (4)
- 596 Detection of Pancreatic High-Grade Dysplasia and Cancer using Novel Methylated DNA Markers: Discovery and Tissue Validation (2016) (4)
- Interference of fecal colonocyte recovery by endogenous cytolysis (1998) (4)
- Discrete event simulation of the cost-effectiveness of colorectal cancer screening by a DNA-based stool test relative to current screening practice (2001) (4)
- Novel methylated DNA markers accurately discriminate Lynch syndrome associated colorectal neoplasia (2020) (4)
- Methylated DNA Markers of Esophageal Squamous Cancer and Dysplasia: An International Study (2020) (4)
- Su1340 Detection of Colorectal Cancer and Polyps in Patients With Inflammatory Bowel Disease by Novel Methylated Stool DNA Markers (2014) (3)
- T2034 Stool DNA and Occult Blood for Detection of Colorectal Cancer: Complementary Markers (2009) (3)
- Comparison of Tissue-Based Molecular Markers in Younger versus Older Patients with Colorectal Neoplasia (2020) (3)
- Methylated Eya4 Gene in Non-Neoplastic Mucosa of Ulcerative Colitis Patients With Colorectal Cancer: Evidence for a Field Effect (2011) (3)
- The Case for a Multitarget Stool DNA Test: A Closer Look at the Cost Effectiveness Model. (2017) (3)
- Su1664 – High Yield of Total and Right-Sided Colorectal Neoplasia by Multi-Target Stool Dna Testing in Average Risk Patients Irrespective of Prior Screening (2019) (3)
- Ileal Kock pouch obstruction secondary to retained medicoliths. (1992) (3)
- 185 Novel Stool DNA Markers for Inflammatory Bowel Disease Associated Colorectal Cancer and High Grade Dysplasia: High Specificity Across Three Independent International Populations (2016) (3)
- Su1213 Stool DNA Testing for Screen-Detection of Colorectal Neoplasia in Alaska Native People (2014) (3)
- 325 Novel Multi-Target Stool DNA Marker Panel Yields Highly Accurate Detection of Colorectal Cancer and Premalignant Neoplasia (2019) (3)
- Multi-Target Stool DNA Test: Is the Future Here? (2016) (3)
- T1105 A Sensitive Method to Scan Gene Mutations in Stool: Relevance to Detection of Gastrointestinal Neoplasia (2008) (3)
- 393 - Multi-Site Gastrointestinal Cancer Detection by Stool DNA (2018) (3)
- Premalignant Conditions of the Gastrointestinal Tract (1991) (3)
- Abstract B12: An optimized molecular stool test for colorectal cancer screening: Evaluation of an automated analytic platform and logistic algorithm (2012) (3)
- 487 Methylated DNA Markers in Pancreatic Juice Discriminate Pancreatic Cancer From Chronic Pancreatitis and Normal Controls (2013) (3)
- dna Methylation Markers for Detection of Extrahepatic Cholangiocarcinoma: Discovery, Tissue validation, and Pilot Testing in Biliary Brush Samples : 169 (2015) (2)
- Stool-Based Tests Vs Screening Colonoscopy for the Detection of Colorectal Cancer. (2019) (2)
- Multi-Target Stool DNA Testing in Patients at Increased Risk for Colorectal Neoplasia Shows Similar Positive Predictive Value to Average Risk Patients (2018) (2)
- Tu1015 – Multi-Target Stool Dna Testing: Yield As a Function of Time Since Last Colonoscopy (2019) (2)
- Rebleeding from peptic ulcers associated with adherent clots: A randomized controlled study comparing endoscopic therapy with medical therapy (1995) (2)
- Assessment of Sponge-on-String Device Parameters for the Non-endoscopic Detection of Barrettʼs Esophagus: Results from a Randomized Trial: 2016 ACG Presidential Poster Award: 506 (2016) (2)
- Improved detection of BAT-26 microsatellite deletions by a modified primer extension assay (2001) (2)
- 481 Noninvasive Detection of Colorectal Neoplasia (CRN) in Inflammatory Bowel Disease (IBD) by Stool DNA Testing: A Pilot Study (2010) (2)
- Gastrointestinal: Colocolonic intussusception by adenocarcinoma arising from diffuse serrated adenoma of the appendix (2011) (2)
- 55 Detection of Barrett's Dysplasia by Assay of Methylated DNA Markers on Whole Esophageal Brushings: A Prospective Feasibility Study (2015) (2)
- Endoscopic transitions in patients undergoing transjugular intrahepatic portosystemic shunts (1995) (2)
- Mo1748 - Validation of Novel Methylated DNA Markers for the Detection of Esophageal Squamous Cell Carcinoma and Dysplasia: Multi-National Tissue Study (2018) (2)
- 372 - Detection of Esophageal Cancer by Assay of Novel Methylated DNA Markers in Plasma (2018) (2)
- W1872 DNA Markers for the Pan-Detection and Site-Prediction of Aerodigestive Cancers: Evaluation of a Candidate Panel (2009) (2)
- Epigenetic silencing of the EYA-4 gene in non-Hodgkin’s lymphoma (NHL (2005) (2)
- A methylated DNA marker panel for the sensitive detection of lung cancer in tissue. (2016) (2)
- Stool DNA for Colorectal Cancer Screening: From Concepts to Quality Care (2015) (2)
- 110 Stool DNA Methylation Markers for the Detection of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease (2012) (2)
- 273 Multi-Target DNA Aberrations in Sporadic Colorectal Cancer Tissues Do Not Differ Between Younger and Older Patients (2019) (2)
- Multi-Target Stool DNA Testing: High Positive Predictive Value Among Average Risk Patients New to Colorectal Cancer Screening (2018) (2)
- HemoQuant test for occult blood: the Sherlock Holmes test? (1984) (2)
- 753 Stool DNA Screening of Colorectal Neoplasia: Improved Adenoma Detection By Novel Digital Melt Curve Assay (2008) (2)
- BMP3 is hypermethylated and may function as a tumor suppressor in cholangiocarcinoma (2008) (1)
- Fecal occult blood screening for colorectal neoplasia (1993) (1)
- Cancer control research in the North Central Cancer Treatment Group (NCCTG). (1989) (1)
- Colorectal Cancer Prevention and Detection (2002) (1)
- Tu1133 - Esophageal Adenocarcinoma Arising on the Background of Barrett's Esophagus is Associated with Better Survival (2018) (1)
- Stool bat-26 testing as adjunct to screening sigmoidoscopy: A feasibility analysis (2001) (1)
- Emerging Prominence of Sessile Serrated Polyps in a Large Colonoscopy Practice: Distribution Trends by Year, Anatomic Site, Age, and Sex: 2131 (2013) (1)
- Sa1899 Fecal Recovery of Ingested Cellular DNA: Implications for Noninvasive Detection of Upper Gastrointestinal Neoplasms (2014) (1)
- Prospective comparison of fecal blood tests for detection of occult gi bleeding: Implications for evaluation of iron deficiency (2000) (1)
- 389 Chronic Diarrhea in Subset of Patients With IBD and IBS is Associated With Altered Microbiota (2014) (1)
- Time Lapse to Colorectal Cancer: Telomere Dynamics Define the Malignant Potential of Polyps (2017) (1)
- Utility of the multitarget stool DNA test for detection of colorectal neoplasia (2017) (1)
- Recurrent cervical carcinoma mimicking rectal cancer. (2010) (1)
- Su1903 Methylated Gene Markers in Stool Before and After Colorectal Cancer Resection: Biologic Implications for Surveillance (2012) (1)
- 863 Stool DNA Markers for the Detection of Neoplasia in Patients With Longstanding Inflammatory Bowel Disease (2016) (1)
- Endoscopic gastric vagotomy: a feasibility study using laser in dogs. (1989) (1)
- Sa1921 Molecular Detection of Colorectal Neoplasia: Do Markers That Target Acquired DNA Alterations in Sporadic Cases Also Discriminate Lynch Syndrome Cases? (2015) (1)
- Mo1370 – Pancreatic Cancer Detection by Plasma Assay of Novel Methylated Dna Markers: A Case-Control Study (2019) (1)
- Candidate stool markers for colorectal cancer screening: An immunohistochemical analysis (1995) (1)
- Gastric Cancer Detection by Novel Methylated DNA Markers: Tissue Validation in Patient Cohorts From the United States and South Korea: 2496 (2015) (1)
- Interval Signet-Ring Cell Adenocarcinoma of the Colon: Missed or De Novo? (2011) (1)
- Colorectal Disease for Physicians and Surgeons (1999) (1)
- Characterization of aberrant crypt foci in human colectomy specimens (1998) (1)
- Abstract 3572: Methylated gene marker levels in stool: effects of demographic, drug, and body mass and other patient characteristics (2012) (1)
- Su1044 Knowledge of a Positive Cologuard™ Result Improves Yield and Quality of Colonoscopy (2016) (1)
- 307 Novel Methylated DNA Markers for the Detection of Colorectal Neoplasia in Lynch Syndrome (2016) (1)
- 1078 – Methylated Dna Markers Detect Esophageal Squamous Dysplasia in Mucosal Tissue and When Sampled by Nonendoscopic Esophageal Balloons: An Exploratory Study (2019) (1)
- Endoscopic detection of aberrant crypt foci by magnification chromoscopy: A blinded comparison against dissecting microscopy and histology in an Ex Vivo model (1998) (1)
- Methylated DNA markers (MDMs) in primary (pCRC) and metastatic colorectal cancers (mCRC). (2019) (1)
- Discovery and validation of novel DNA methylation markers for the detection of endometrial cancer: Selection by methylome-wide analysis (2019) (1)
- Tu1281 Aberrant Methylation During Gastric Carcinogenesis: Patterns of Acquisition Using Novel Methylated DNA Markers From Whole Methylome Discovery (2016) (1)
- Referee Acknowledgement for 2012 (2013) (0)
- Thanks to Reviewers2001 (2001) (0)
- A Next Generation Stool DNA Test (NG-Sdna) for Colorectal Cancer Screening: Factors Affecting Neoplasm Detection (2011) (0)
- Book ReviewsGastroenterologic EndoscopyGastroenterologic Endoscopy, Michael V. Sivak Jr. (Ed.), W. B. Saunders Company, Philadelphia (1987), p. 1,168 pp, with illus, $150 (1988) (0)
- Method of proof of lungenneoplasmen rehearse in fecal (2000) (0)
- Abstract PL02-01: Stool DNA detection of colorectal neoplasia: A new high bar for noninvasive screening (2015) (0)
- 861 Highly Discriminant Methylated DNA Markers for Detection of Barrett's Esophagus (2014) (0)
- Multicancer early detection: International summit to Clarify the Roadmap (2022) (0)
- The effectiveness of colonoscopy in reducing mortality from colorectal cancer. (2009) (0)
- Expanding metal stents are more cost effective than laser photoablation therapy for palliation of inoperable esophageal carcinoma (1998) (0)
- Tu1447 Endoscopic Over-Estimation of Polyp Size and Factors Influencing Degree of Bias (2014) (0)
- Book Reviews (1917) (0)
- Sa1646 - Effect of Barrett's Esophagus on Screeening Performance of Multi-Target Stool Dna Test (2018) (0)
- Prediction of inflammatory bowel disease in patients with nonbloody diarrhea: Prospective comparison of fecal calprotectin and heme assays (1998) (0)
- 418 Clinical translation of methylated DNA markers of endometrial cancer using tampon-based detection (2020) (0)
- Multi-Target Stool DNA Has a High Positive Predictive Value as an Interval Test After Colonoscopy (2018) (0)
- Demystification of the occult with HemoQuant. (1987) (0)
- A Comprehensive Approach to Sequence-oriented IsomiR annotation (CASMIR): demonstration with IsomiR profiling in colorectal neoplasia (2018) (0)
- Stool DNA testing: a new, noninvasive option for colorectal cancer screening. (2015) (0)
- Colorectal endoscopy (1994) (0)
- Mo1005 – Heartburn and the American College of Gastroenterology Criteria for Barrett’s Screening are Limited in Detecting De Novo and Non-Intestinal Metaplasia Phenotype of Esophageal Adenocarcinoma (2019) (0)
- Colorectal Adenocarcinoma (2021) (0)
- Mo1716 Long-Term Follow-Up of Patients Having False Positive Multi-Target Stool DNA Tests After Negative Screening Colonoscopy: The LONG-HAUL Study (2016) (0)
- Altered MLH1 and MSH2 expression in colorectal cancer is associated with proximal site but not risk of metachronicity: Results of a case-control study (1998) (0)
- Colonoscopy. (1977) (0)
- Audit of Leicester's Social Economy (1999) (0)
- Molecular detection of pancreatic neuroendocrine tumors using methylated DNA markers: Discovery and tissue validation. (2020) (0)
- 304 Novel Approach to Fecal Occult Blood Testing With Erythrocyte-Specific microRNA Markers (2016) (0)
- Response. (2019) (0)
- Acknowledgment of 2018 Reviewers (2019) (0)
- Mo1676 COST EFFECTIVENESS OF MULTI-TARGET STOOL DNA TEST VERSUS COLONOSCOPY OR FECAL IMMUNOCHEMICAL TEST FOR COLORECTAL CANCER SCREENING AMONG ALASKA NATIVE PEOPLE (2020) (0)
- Tu2032 – Addition of Preservative Buffer Improves Dna Yield from Endoscopically Collected Pancreatic Juice and Facilitates Detection of Pancreatic Ductal Adenocarcinoma Using Methylated Dna Markers (2019) (0)
- 1084 INDEPENDENT VALIDATION OF AN ACCURATE METHYLATED DNA MARKER PANEL FOR THE NON-ENDOSCOPIC DETECTION OF BARRETT'S ESOPHAGUS : A MULTISITE CASE CONTROL STUDY (2020) (0)
- NOVEL DNA METHYLATION MARKERS FOR ACCURATE PROGNOSTIC ASSESSMENT OF PROSTATE CANCER: DISCOVERY AND EARLY VALIDATION: PD71‐03 (2017) (0)
- Colorectal neoplasia: diagnosis and screening (1990) (0)
- IGCS 20 _ 1454 417 KRAS MUTANT UTERINE CARCINOMAS (2020) (0)
- PTU-055 Comparative cost-effectiveness of gastroesophageal reflux disease (GORD) centric and population based barrett’s oesophagus (BO) screening (2019) (0)
- Epidemiology, etiology, diagnosis, and screening of colorectal neoplasia (1991) (0)
- Abstract A22: Sensitive detection of mutant KRAS in colorectal tissue using the multiplex QuARTS™ assay (2011) (0)
- PROGNOSTIC FACTORS RELATED TO RECURRENCE AND SURVIVAL OF EARLY STAGE VULVAR SQUAMOUS CELL CARCINOMA (2020) (0)
- Colorectal Cancer Prevention (Abstracts 217-313) (2018) (0)
- Iconographies supplémentaires de l'article : Endoscopic overestimation of colorectal polyp size (2016) (0)
- Long-Term Follow-up of Patients Having False Positive Multi-target Stool DNA Tests after Negative Screening Colonoscopy : The LONG-HAUL Cohort Study Running Title : Long-Term Outcomes of False Positive Multi-target Stool DNA (2016) (0)
- Sa1021 Cost-Effectiveness Analysis of Stool DNA or Colonoscopy for Colorectal Neoplasia Surveillance in Patients With Ulcerative Colitis (2015) (0)
- Thanks to Reviewers2000 (2000) (0)
- Advances in Colorectal Cancer Screening (2012) (0)
- Detection of Gastric Cancer by Assay of Novel Methylated DNA Markers in Plasma: 1145 (2016) (0)
- Synchronous colorectal carcinoma: Presence and concordance of DNA mismatch repair enzyme expression (2000) (0)
- Another look at colorectal cancer screening benefits (2000) (0)
- Precancerous Lesions of the Gastrointestinal Tract (1984) (0)
- Prospective evaluation of urinary transforming growth factor alpha levels for predicting clinical important colorectal neoplasia (1998) (0)
- Statistical issues addressed in a large screening trial (1991) (0)
- T1099 Pancreatic Cancer Detection By Stool Testing: Pilot Study Targeting Proteomic Markers (2008) (0)
- Hemoquant--an approach to screening for fecal occult blood. (1985) (0)
- Methylated DNA marker panel for metastatic melanoma: Discovery and tissue validation. (2020) (0)
- Gastric vascular ectasia do not improve with reduction of portal pressure by transjugular intrahepatic portosystemic shunts (TIPS) (1998) (0)
- T1117 Stool DNA for Detection of Gastrointestinal Neoplasia: Effect of Lesion Site (2008) (0)
- Comment on “Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population” (2017) (0)
- Thanks to authors and peer reviewers (2008) (0)
- Su1885 DNA Methylation Markers for the Specific and Universal Detection of Colorectal Neoplasia: Selection by Deep Sequencing (2012) (0)
- Prevalence of ileal neoplasms and colonic metaplasia in familial adenomatous polyposis patients after proctocolectomy: A prospective study (2001) (0)
- Su1359 Aberrant DNA Methylation of Colonic Serrated Lesions and Subsequent Colorectal Neoplasia in Ulcerative Colitis and Crohn's Colitis (2014) (0)
- A computerized colorectal cancer prevention registry and risk assessment tool (1998) (0)
- P-280 Aberrant promoter methylation of sFRP1, sFRP2 and sFRP5 is a common epigenomic event in lung adenocarcinomas (2003) (0)
- Acknowledgment of 2008 Reviewers (2009) (0)
- Su2013 Methylated DNA Markers for Detection of Sporadic Colorectal Neoplasia: Comparison Between Age Groups Younger Than and Older Than 50 (2016) (0)
- 781 Sensitive DNA Marker Panel for Detection of Pancreatic Cancer by Assay in Pancreatic Juice (2014) (0)
- Abstract CN13-03: Next-generation stool DNA testing (2010) (0)
- Nanopore-BasedAssayforDetectionof Methylation in Double-Stranded DNA (2015) (0)
- 1046 A Stool-Based MicroRNA and DNA Marker Panel for the Detection of Pancreatic Cancer (2014) (0)
- Cancer of the colon, rectum, and anus: Edited by Alfred M. Cohen, Sidney J. Winawer, Michael A. Friedman, and Leonard L. Gunderson. 1154 pp. $125.00. McGraw-Hill, Hightstown, New Jersey, 1995. ISBN 0-07-011601-6 (1995) (0)
- Altered stool DNA as a predictor of advanced neoplastic colonic polyps (2001) (0)
- Colorectal Cancer Screening with CT Colonography , Colonoscopy , and Double-Contrast Barium Enema Examination : Prospective Assessment of Patient Perceptions and Preferences 1 (2003) (0)
- Prevalence and Outcomes of Colonic Serrated Epithelial Changes in Patients with Ulcerative Colitis and Crohnʼs Colitis: 1795 (2013) (0)
- Stool DNA testing for colorectal cancer shows promise (2008) (0)
- Novel DNA Methylation Markers Assayed from Cyst Fluid Accurately Detect Advanced Neoplasia in Pancreatic Cysts: A Multicenter Study (2017) (0)
- Molecular characterization of colorectal adenomas with and without malignancy reveals distinguishing genome, transcriptome and methylome alterations (2018) (0)
- W1295 Defining the Soluble Proteome of Human Stool (2008) (0)
- Detection of Advanced Neoplasia in Pancreatic Cysts by Assay of Novel DNA Methylation Markers in Cyst Fluid: A Multicenter Pilot Study: 2016 ACG Fellows-In-Training Award (Biliary/Pancreas Category): 2 (2016) (0)
- Colorectal cancer prevention and detection. Introduction. (2002) (0)
- Comparative Cost-Effectiveness of Gastroesophageal Reflux Disease Centric and Population Based Barrett’s Esophagus Screening: Fellows-in-Training Award (Esophagus Category) (2018) (0)
- Sa1050 Prevalence of DNA Biomarkers in Fecal Immunochemical Test Positive and Negative Colorectal Cancers (2015) (0)
- PD56-11 ANALYSIS OF METHYLATED DNA MARKERS FOR PREDICTION OF CANCER PROGRESSION AFTER RADICAL PROSTATECTOMY (2018) (0)
- Response to Kosmidou et al. (2018) (0)
- Screen detection of serrated polyps by stool DNA multi-target testing (sDNA-MT): Comparison against fecal immunochemical occult blood testing (FIT). (2013) (0)
- Detection of Pancreatic Cancer by Assay of Novel Methylated DNA Markers in Pancreatic Juice: A Blinded Prospective Multi-Site Study (2017) (0)
- Pathophysiology of Gastrointestinal Diseases (1990) (0)
- Magnetophoretic-based microfluidic device for DNA Concentration (2016) (0)
- Influence of Aerodigestive Tract Radiation on Multi-Target Stool DNA Screening for Colorectal Cancer (2018) (0)
- Techniques in Therapeutic Endoscopy (1987) (0)
- Abstract IA13: Stool DNA detection of colorectal neoplasia (2017) (0)
- Discriminant accuracy of fecal calprotectin and hemoquant assays for detection of inflammatory disease in dyspeptic patients: Prospective comparison against endoscopy* (1998) (0)
- W1876 Stool Protein Markers for Colorectal Cancer: Identification of High-Abundance Candidates By Mass Spectroscopy (2009) (0)
- A Discriminant DNA Marker Panel for Detection of Colorectal Adenomas: 1083 (2005) (0)
- Pandemic occult gastrointestinal bleeding among Yupik Eskimos Role of Helicobacter pylori (1994) (0)
- Su2001 Differential IsomiR Expression in Colorectal Neoplasia (2016) (0)
- Reexamining Risk Factors for High-Grade Dysplasia in Colorectal Polyps: 755 (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With David A. Ahlquist?
David A. Ahlquist is affiliated with the following schools:
